• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Pays $266.3 Million to Tap Brazilian Market More...
• Sangart, Inc. Grabs $50 Million Series G Funding More...
• Royalty Pharma Raises $600 Million of Debt More...
• Immune Response BioPharma Terminates Blockbuster MS Drug NeuroVax Partnership Discussions With GlaxoSmithKline (GSK) More...
• Basilea Pharmaceutica (BSLN.SW) Participates in Public-private Collaboration to Tackle Antibiotic Resistance More...
• Acasti Pharma Announces Year End Results and Corporate Reorganization More...
• Oncobiologics Inc. Fills Key Leadership Positions and Names Scientific Advisory Board More...
• Safeguard Scientifics (SFE) Appoints Dr. Keith B. Jarrettto Board of Directors More...
• China Kanghui Holdings Reports First Quarter 2012 Financial Results More...
• Abstral EU Success Continues. Orexo AB Receives Sales Milestone of 3.3 MEUR. More...
• Taro Pharmaceutical Industries Ltd. (TARO) Provides Results for Three Months Ended March 2012 More...
• Tekmira Pharmaceuticals Corporation Provides Periodic Update to Shareholders Regarding Litigation More...
• Court Orders Dismissal of Cornerstone Therapeutics Inc. CUROSURF(R) Case More...
• Marken (Formerly known as Marken Time Critical) Opens Branch Office In Seoul, South Korea More...
• Synthetic Genomics, Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains More...
• Eli Lilly and Company (LLY): Type 2 Diabetes Drug Safe and Effective in African Americans in Phase III Study More...
• European Medicines Evaluation Agency Confirms Boehringer Ingelheim Corporation's Pradaxa Benefits, But Wants Clearer Guidance More...
• GlaxoSmithKline (GSK) Diabetes Drug Data Revealed Amid Hostile Takeover More...
• Elan Pharmaceuticals (ELN) Hoping Alzheimer's Drug Will "Transform" Firm More...
• Summit Corporation: Summit Announces Initiation of Phase 1 Trial for the Treatment of Duchenne Muscular Dystrophy More...
• Obesity Not Always Tied to Higher Heart Risk, University College London Study More...
• No New Neurons in the Human Olfactory Bulb, Karolinska Institute Study More...
• Babies Zero in on "Just Right" to Learn, University of Rochester Study More...
• Japanese-American Men With Low Vitamin-D Diet Face Higher Stroke Risk, University of Hawaii Study More...
• Combo Therapy May Help Ease "Ringing in the Ears," Maastricht UniversityStudy More...
• Watson Pharmaceuticals, Inc. (WPI) Confirms Testim® Patent Challenge More...
• Mylan Inc. (MYL) Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy More...
• Sangart, Inc. Grabs $50 Million Series G Funding More...
• Royalty Pharma Raises $600 Million of Debt More...
• Immune Response BioPharma Terminates Blockbuster MS Drug NeuroVax Partnership Discussions With GlaxoSmithKline (GSK) More...
• Basilea Pharmaceutica (BSLN.SW) Participates in Public-private Collaboration to Tackle Antibiotic Resistance More...
• Acasti Pharma Announces Year End Results and Corporate Reorganization More...
• Oncobiologics Inc. Fills Key Leadership Positions and Names Scientific Advisory Board More...
• Safeguard Scientifics (SFE) Appoints Dr. Keith B. Jarrettto Board of Directors More...
• China Kanghui Holdings Reports First Quarter 2012 Financial Results More...
• Abstral EU Success Continues. Orexo AB Receives Sales Milestone of 3.3 MEUR. More...
• Taro Pharmaceutical Industries Ltd. (TARO) Provides Results for Three Months Ended March 2012 More...
• Tekmira Pharmaceuticals Corporation Provides Periodic Update to Shareholders Regarding Litigation More...
• Court Orders Dismissal of Cornerstone Therapeutics Inc. CUROSURF(R) Case More...
• Marken (Formerly known as Marken Time Critical) Opens Branch Office In Seoul, South Korea More...
• Synthetic Genomics, Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains More...
• Eli Lilly and Company (LLY): Type 2 Diabetes Drug Safe and Effective in African Americans in Phase III Study More...
• European Medicines Evaluation Agency Confirms Boehringer Ingelheim Corporation's Pradaxa Benefits, But Wants Clearer Guidance More...
• GlaxoSmithKline (GSK) Diabetes Drug Data Revealed Amid Hostile Takeover More...
• Elan Pharmaceuticals (ELN) Hoping Alzheimer's Drug Will "Transform" Firm More...
• Summit Corporation: Summit Announces Initiation of Phase 1 Trial for the Treatment of Duchenne Muscular Dystrophy More...
• Obesity Not Always Tied to Higher Heart Risk, University College London Study More...
• No New Neurons in the Human Olfactory Bulb, Karolinska Institute Study More...
• Babies Zero in on "Just Right" to Learn, University of Rochester Study More...
• Japanese-American Men With Low Vitamin-D Diet Face Higher Stroke Risk, University of Hawaii Study More...
• Combo Therapy May Help Ease "Ringing in the Ears," Maastricht UniversityStudy More...
• Watson Pharmaceuticals, Inc. (WPI) Confirms Testim® Patent Challenge More...
• Mylan Inc. (MYL) Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy More...
0 comments